CD82 and cancer: Significantly, RUVBL2 was found to be recruited to the promoter of KAI-1 in a complex with β-catenin resulting in the repression of KAI-1 expression, a metastasis suppressor protein, thus contributing to the enhanced invasion ability of cancer cells [22].